What is the price target for GME stock?
5 analysts have analysed GME.DE and the average price target is 6.12 EUR. This implies a price increase of 118.57% is expected in the next year compared to the current price of 2.8.
GERATHERM MEDICAL AG (GME.DE) Forecast, Price Target & Analyst Ratings
FRA:GME • DE0005495626
Current stock price
2.8 EUR
+0.1 (+3.7%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GERATHERM MEDICAL AG (GME.DE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€6.12
Upside
+ 118.57%
From current price of €2.80 to mean target of €6.12, Based on 5 analyst forecasts
Low
€6.06
Median
€6.12
High
€6.30
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for GME.DE. The average price target is 6.12 EUR. This implies a price increase of 118.57% is expected in the next year compared to the current price of 2.8.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
GME.DE was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about GME.DE.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed GME.DE. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jun 2, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2029
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25.851M 7.98% | 20.956M -18.94% | 13.98M -33.29% | 15.756M 12.70% | 16.665M 5.77% | 17.675M 6.06% | N/A | N/A | |
| EBITDA YoY % growth | 3.776M 35.97% | 4.4M 16.53% | 3.354M -23.78% | 1.616M -51.81% | 1.919M 18.75% | 2.424M 26.32% | 2.771M 14.32% | 3.107M 12.13% | |
| EBIT YoY % growth | 2.3M 116.57% | 2.679M 16.48% | 1.496M -44.18% | -100.00% | 505K | 1.111M 120.00% | N/A | N/A | |
| Operating Margin | 8.90% | 12.78% | 10.70% | N/A | 3.03% | 6.29% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A 340.68% | N/A -80.77% | 0.01 -80.00% | 0.06 500.00% | 0.11 83.33% | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
30.06%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-0.56%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
71.00%
EBIT Next 5 Year
42.35%
GERATHERM MEDICAL AG / GME.DE Forecast FAQ
Can you provide the upcoming earnings date for GERATHERM MEDICAL AG?
GERATHERM MEDICAL AG (GME.DE) will report earnings on 2026-06-02, after the market close.
What is the expected long term growth rate for GME stock?
The expected long term growth rate for GERATHERM MEDICAL AG (GME.DE) is -0.56%.